Loading...
Loading...
Contributors:
Dataset URI:
b312447a-ad76-4c8c-8b57-0edf15a30658This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as a three-dose primary vaccination course at 2, 4 and 6 months of age, in terms of safety and immunogenicity in different population of infants residing in Canada.
Keyword(s):
Acellular Pertussis; Acellular Pertussis Vaccine / Diphtheria Toxoid Vaccine / Tetanus Toxoid Vaccine Injectable Suspension [infanrix]; Diphtheria; Haemophilus Influenzae Type b; Healthy.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)